Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 1/2 1Phase 1 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Hodgkin Disease 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

pembrolizumab 514Specimen Handling 384Carboplatin 372Magnetic Resonance Spectroscopy 337Cisplatin 327Nivolumab 301Cyclophosphamide 297Radiotherapy 255Paclitaxel 255Biopsy 237Gemcitabine 229Bevacizumab 212Dexamethasone 168durvalumab 162Oxaliplatin 159Capecitabine 154Rituximab 153Fluorouracil 148venetoclax 143atezolizumab 142Drug Therapy 140Docetaxel 140Etoposide 139Doxorubicin 132Ipilimumab 124Lenalidomide 119Radiosurgery 118Prednisone 116Leucovorin 112fludarabine 109

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Biopsy, Large-Core Needle × 1 year × Clear all
NCT03418038 2026-04-16

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Mayo Clinic

Phase 2 Recruiting
80 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

NCT04067726 2026-03-31

TRIDENT

Washington University School of Medicine

Phase 2 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

NCT04009044 2025-10-09

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Northwestern University

Phase 2 Active not recruiting
156 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡